Mesoblast Ltd has released a press release.
Positive Nine Month RA Results For Mesoblast Cell Therapy
Filed with ASX ·
Watch Mesoblast's latest callMesoblast (ASX:MSB) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mesoblast (ASX:MSB) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
In the deck
Earlier from Mesoblast
- Published Results Show MSB Cells Effective In RA Model
- Mesoblast Director Recognized For Cardiovascular Leadership
- Mesoblast And Mallinckrodt Enter Into Agreement
- MD Anderson and NIH Fund Trial Using Mesoblast Technologies
- First Quarter Results On Form 6K
Later from Mesoblast
- FDA Grants Mesoblast Fast Track Designation For GVHD
- Durable Three Year Outcomes in Disc Disease
- Mesoblast Raises US$40 Million
- Process Initiated For CHF P3 Interim Analysis
- FDA Clears Heart Disease Trial At Boston Childrens Hospital
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast